Home - Products - Others - Other Targets - 4,5-Dibromo-1H-Pyrrole-2-Carboxylic Acid

4,5-Dibromo-1H-Pyrrole-2-Carboxylic Acid

CAS No. 34649-21-3

4,5-Dibromo-1H-Pyrrole-2-Carboxylic Acid( 4,5-Dibromo-2-pyrrolic acid | 4,5-dibromopyrrole-2-carboxylic acid )

Catalog No. M29536 CAS No. 34649-21-3

4,5-Dibromo-1H-Pyrrole-2-Carboxylic Acid is a marine derived natural products found in Agelas oroides.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4,5-Dibromo-1H-Pyrrole-2-Carboxylic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    4,5-Dibromo-1H-Pyrrole-2-Carboxylic Acid is a marine derived natural products found in Agelas oroides.
  • Description
    4,5-Dibromo-1H-Pyrrole-2-Carboxylic Acid is a marine derived natural products found in Agelas oroides.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    4,5-Dibromo-2-pyrrolic acid | 4,5-dibromopyrrole-2-carboxylic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    34649-21-3
  • Formula Weight
    268.89
  • Molecular Formula
    C5H3Br2NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(O)C1=CC(Br)=C(Br)N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Tubuloside A

    Tubuloside A ( 8.6 microM) can inhibit D-galactosamine-induced death of hepatocytes. Tubuloside A has NO radical-scavenging activity, which possibly contributes to its anti-inflammatory effects.

  • BC-1382

    BC-1382 is a potent ubiquitin E3 ligase HECTD2 inhibitor that specificly disrupts the HECTD2/PIAS1 interaction(IC50 of 5 nM).BC-1382, that targeted HECTD2 and attenuated lipopolysaccharide (LPS)- and Pseudomonas aeruginosa-induced lung inflammation.?

  • Kira8

    Kira8 is a mono-selective IRE1α inhibitor that allosterically attenuates IRE1α RNase activity (IC50: 5.9 nM).